Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Anxiety Stress Coping. 2013 Nov 28;27(3):253–269. doi: 10.1080/10615806.2013.852185

Table 2.

Mean (SD) HPA Activity by Group

Variable Total Sample (N = 104) PTSD+/− MDD+/− Comorbidity Classification
PTSD+ (N = 68) PTSD− (N = 36) F-test (df)
p-value
MDD+ (N = 55) MDD− (N = 49) F-test (df)
p-value
No PTSD or MDD (N = 24) MDD Only (N = 12) PTSD Only (N = 25) PTSD & MDD (N = 43) F-test (df)
p-value
Waking 11.95 (7.25) 11.69 (7.66) 12.45 (6.50) .74 (8,95)
.39
10.25 (6.06) 13.86 (8.04) 5.11 (8,95)
.03
13.99 (7.12) 9.38 (3.62) 13.73 (8.98) 10.50 (6.60) 1.69 (10,93)
.18
AUCg 833.88 (406.40) 858.39 (449.30) 787.59 (310.22) 1.14 (8,95)
.29
816.28 (413.50) 853.63 (401.62) .06 (8,95)
.80
825.03 (352.23) 712.72 (193.97) 881.10 (449.56) 845.19 (453.94) .58 (10,93)
.63
AUCi 116.81 (317.37) 157.23 (339.24) 40.46 (258.74) 6.75 (8,95)
.01
201.05 (319.35) 22.24 (290.08) 8.44 (8,95)
.01
−14.17 (271.42) 149.72 (198.60) 57.20 (308.38) 215.38 (346.16) 3.62 (10,93)
.02

Waking = waking cortisol (nmol/dl); AUCg = Area Under the Curve with Respect to Ground (nmol/dl); AUCi = Area Under the Curve with Respect to Increase (nmol/dl).

Note: All F-values control for age, chronicity, minority status, anti-anxiety medication, other Anxiety Disorders, Bipolar Spectrum Disorder and time between waking and first saliva sample.